Latest On Anixa Biosciences, Inc (ANIX):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-04-18 20:27 EST | News | Anixa: I Am More Bullish After Efficacy Data For Its Triple-Negative Breast Cancer Vaccine | N/A |  |
| 2022-08-16 04:17 EST | News | Anixa adds 11% after dosing initiation in CAR-T ovarian cancer trial | N/A | |
| 2022-07-22 11:56 EST | News | Anixa to get additional US patent linked to breast cancer vaccine technology | N/A | |
| 2022-05-27 00:36 EST | News | Anixa Biosciences (ANIX) Investor Presentation - Slideshow | N/A | |
| 2022-05-11 18:58 EST | News | Anixa: Making Sense Of A Bullish Move Up In Bearish Biotech Times | N/A | |
| 2022-03-31 06:50 EST | News | Anixa Biosciences initiates phase 1 trial of its ovarian cancer CAR-T therapy | N/A | |
| 2022-01-24 16:54 EST | News | Anixa says new protease inhibitor outperformed main agent in Pfizer’s COVID-19 pill | N/A | |
| 2021-12-08 02:14 EST | News | Anixa Bio says its COVID-19 compounds are expected to be effective against Omicron variant | N/A | |
| 2021-10-26 12:03 EST | News | Anixa Biosciences gets dosing underway in breast cancer vaccine study | N/A | |
| 2021-10-19 05:32 EST | News | Warning: ANIX is at high risk of performing badly | N/A | |
| 2021-10-07 04:24 EST | News | Anixa Biosciences nabs first Chinese patent for CAR-T cancer therapy technology | N/A | |
| 2021-10-02 06:19 EST | News | Anixa Biosciences gets notice of allowance for additional patent on its CAR-T cancer therapy | N/A | |
| 2021-10-02 06:19 EST | News | Anixa Bio nabs new U.S. patent for its CAR-T cancer therapy (duplicate) | N/A | |
| 2021-09-23 22:45 EST | News | Our First Look At Anixa Biosciences | N/A | |
| 2021-08-31 03:17 EST | News | Anixa Bio gets FDA green light to initiate trial of ovarian cancer CAR-T immunotherapy | N/A | |
| 2021-08-25 12:46 EST | News | Anixa Biosciences' COVID-19 compounds show promise against Delta variant | N/A | |
| 2021-04-20 01:13 EST | News | Anixa Biosciences places CAR-T therapy study on hold | N/A | |
| 2021-04-12 15:59 EST | News | Twist Bioscience and Codexis in focus as Piper Sandler upbeat on synthetic biology, and more in today’s analyst action | N/A | |
| 2021-04-05 22:51 EST | News | Anixa advancing COVID-19 antiviral candidates to preclinical stage | N/A | |
| 2021-03-23 18:58 EST | News | Anixa Biosciences plunges on upsizing stock offering to $22.5M | N/A | |
| 2021-03-22 22:28 EST | News | Anixa Biosciences to raise $10M in bought deal offering | N/A | |
| 2021-03-15 08:06 EST | Earnings Estimate | An EPS average of -$0.14 is estimated for the quarter ending on July 31, 2021. | Sell | |
| 2021-03-12 20:16 EST | News | Anixa Bio shares surge 35% on European patent for ovarian cancer vaccine technology | N/A | |
| 2021-03-12 07:07 EST | Financials | Company financials have been released. | Neutral | |
| 2021-03-04 17:31 EST | News | Anixa issued European patent for CAR-T cancer therapy | N/A | |
| 2021-01-11 07:07 EST | Earnings Estimate | An EPS average of -$0.59 is estimated for the 2022 year. | Sell | |
| 2021-01-11 07:07 EST | Earnings Estimate | An EPS average of -$0.12 is estimated for the quarter ending on April 30, 2021. | Sell | |
| 2021-01-09 11:06 EST | Financials | Company financials have been released. | Neutral | |
| 2020-12-13 03:11 EST | Financials | Company financials have been released. | Neutral | |
| 2020-12-02 15:59 EST | News | Anixa Biosciences, Cleveland Clinic in ovarian cancer vaccine pact | N/A | |
| 2020-11-15 11:10 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-01 17:02 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 04:13 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-14 09:46 EST | Insider Trade | Lewis H jr Titterton has directly acquired 40,000 shares and currently holds 1,020,326 shares. | Buy | |
| 2020-09-11 12:15 EST | Insider Trade | AMIT KUMAR has directly acquired 28,000 shares and currently holds 262,000 shares. | Buy | |
| 2020-09-11 12:06 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-10 12:06 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-10 04:06 EST | Earnings Estimate | An EPS average of -$0.13 is estimated for the quarter ending on January 31, 2021. | Sell | |
| 2020-07-31 00:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-28 12:06 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 16:14 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-13 04:08 EST | Analyst Rating | The Analyst Target Price has increased from $8.25 to $8.75. | Buy | |
| 2020-07-11 07:58 EST | News | Anixa nabs European patent covering CAR-T technology | N/A | |
| 2020-07-07 02:28 EST | News | Anixa and OntoChem identify potential COVID-19 candidates | N/A | |
| 2020-07-03 04:13 EST | News | Anixa realigns with focus on its therapeutic and vaccine Pipeline | N/A | |
| 2020-06-17 11:01 EST | Insider Trade | Lewis H jr Titterton has directly acquired 24,500 shares and currently holds 980,326 shares. | Buy | |
| 2020-06-16 11:46 EST | Insider Trade | Lewis H jr Titterton has directly acquired 31,083 shares and currently holds 955,826 shares. | Buy | |
| 2020-06-12 11:01 EST | Insider Trade | AMIT KUMAR has directly acquired 20,000 shares and currently holds 234,000 shares. | Buy | |
| 2020-06-12 04:07 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-01 18:51 EST | News | Anixa rallies on development of four COVID-19 candidates | N/A | |
About Anixa Biosciences, Inc (ANIX):
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the treatment of ovarian cancer; and the discovery and development of anti-viral drug candidates for the treatment of COVID-19 focused on inhibiting certain viral protein functions of the virus. Its vaccine programs comprise the development of a vaccine against triple negative breast cancer; and a vaccine against ovarian cancer. The company is also developing immuno-therapy drugs against cancer. It has a collaboration agreement with OntoChem GmbH to discover and develop anti-viral drug candidates against COVID-19. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was founded in 1982 and is based in San Jose, California.
General
- Name Anixa Biosciences, Inc
- Symbol ANIX
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDiagnostics & Research
- Full Time Employees 3
- Last Split Factor1:1
- Last Split Date2016-10-18
- Fiscal Year EndOctober
- IPO Date1987-01-01
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryBiotechnology
- Gic SubIndustryBiotechnology
- Web URLhttp://www.anixa.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 152.51
- Price/Book (Most Recent Quarter) 15.06
- Enterprise Value Revenue 136.42
View More
Financials
- Most Recent Quarter 2021-01-31
- Current Year EPS Estimate -$0.50
- Next Year EPS Estimate -$0.60
- Operating Margin -1804%
- Return on Assets -56%
- Return on Equity -107%
- Revenue 512500
- Earnings Per Share -$0.77
- Revenue Per Share $0.02
- Gross Profit 83750
- Quarterly Earnings Growth 0%
View More
Highlights
- Market Capitalization 186.67 million
- EBITDA -13628274
- Analyst Target Price $8.75
- Book Value Per Share $0.52
View More
Share Statistics
- Shares Outstanding 26.71 million
- Shares Float 25.51 million
- % Held by Insiders 596%
- % Held by Institutions 7.72%
- Shares Short 497679
- Shares Short Prior Month 479168
- Short Ratio 1.39
- Short % of Float 2%
- Short % of Shares Outstanding 2%
View More
Technicals
- Beta 1.57
- 52 Week High $8.09
- 52 Week Low $1.33
- 50 Day Moving Average 4.98
- 200 Day Moving Average 3.26
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Anixa Biosciences, Inc (ANIX) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Anixa Biosciences, Inc (ANIX) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2021-01-31 | 2021-03-11 | $512500 | -$0.07 | -$0.12 | 36.96% |
| 2020-10-31 | 2021-01-07 | $N/A | -$0.09 | -$0.11 | 18.18% |
| 2020-07-31 | 2020-09-08 | $N/A | -$0.11 | -$0.12 | 8.33% |
| 2020-04-30 | 2020-06-09 | $N/A | -$0.12 | -$0.13 | 7.69% |
| 2020-01-31 | 2020-03-09 | $N/A | -$0.13 | -$0.13 | 0% |
| 2019-10-31 | 2020-01-09 | $N/A | -$0.10 | -$0.24 | 58.33% |
| 2019-07-31 | 2019-09-06 | $N/A | -$0.11 | -$0.23 | 52.17% |
| 2019-04-30 | 2019-06-12 | $250000 | -$0.13 | -$0.23 | 43.48% |
| 2019-01-31 | 2019-03-13 | $N/A | -$0.23 | -$0.15 | -55.2% |
| 2018-10-31 | 2019-01-11 | $-362500 | -$0.26 | -$0.15 | -74.07% |
| 2018-07-31 | 2018-09-07 | $362500 | -$0.30 | ||
| 2018-04-30 | 2018-06-11 | $750000 | -$0.08 | ||
| 2018-01-31 | 2018-03-09 | $N/A | -$0.11 | ||
| 2017-10-31 | 2018-01-09 | $-500 | -$0.11 | ||
| 2017-07-31 | 2017-09-08 | $363000 | -$0.12 | ||
| 2017-04-30 | 2017-05-26 | $N/A | $0.02 | ||
| 2017-01-31 | 2017-03-16 | $N/A | -$0.41 | ||
| 2016-10-31 | 2016-12-07 | $200000 | -$0.12 | ||
| 2016-07-31 | 2016-08-19 | $100000 | -$0.13 | ||
| 2016-04-30 | 2016-05-20 | $N/A | -$0.15 | ||
| 2016-01-31 | 2016-03-08 | $N/A | -$0.18 | ||
| 2015-10-31 | 2015-12-30 | $160000 | -$0.15 | ||
| 2015-07-31 | 2015-09-15 | $95000 | -$0.18 | ||
| 2015-04-30 | 2015-05-22 | $25000 | -$0.26 | ||
| 2015-01-31 | 2015-03-10 | $9.14 million | $0.41 | ||
| 2014-10-31 | 2015-01-29 | $1.38 million | -$0.36 | ||
| 2014-07-31 | 2014-09-16 | $1.19 million | $0.05 | ||
| 2014-04-30 | 2014-06-16 | $1.11 million | -$0.38 | ||
| 2014-01-31 | 2014-03-18 | $N/A | -$0.43 | ||
| 2013-10-31 | 2014-01-14 | $389000 | -$0.35 | ||
| 2013-04-30 | 2013-06-10 | $N/A | -$0.32 | ||
| 2013-01-31 | 2013-03-19 | $2130 | -$0.28 | ||
| 2012-10-31 | 2013-01-15 | $-127150 | -$0.26 | ||
| 2012-07-31 | 2012-09-11 | $250000 | -$0.09 | ||
| 2012-04-30 | 2012-06-11 | $248000 | -$0.12 | ||
| 2012-01-31 | 2012-03-20 | $449000 | -$0.12 | ||
| 2011-10-31 | 2012-01-17 | $449000 | -$0.42 | ||
| 2011-07-31 | 2011-09-13 | $450000 | -$0.26 | ||
| 2011-04-30 | 2011-06-13 | $87000 | -$0.19 | ||
| 2011-01-31 | 2011-03-22 | $17000 | -$0.24 | ||
| 2010-10-31 | 2011-01-18 | $312000 | -$0.19 | ||
| 2010-07-31 | 2010-09-14 | $58000 | -$0.21 | ||
| 2010-04-30 | 2010-06-14 | $322000 | -$0.22 | ||
| 2010-01-31 | 2010-03-23 | $39000 | -$0.26 | ||
| 2009-10-31 | 2010-01-12 | $119000 | -$2.25 | ||
| 2009-07-31 | 2009-09-10 | $300000 | -$0.21 | ||
| 2009-04-30 | 2009-06-19 | $263000 | -$0.24 | ||
| 2009-01-31 | 2009-03-17 | $374000 | -$0.26 | ||
| 2008-10-31 | 2009-01-13 | $963000 | -$0.25 | ||
| 2008-07-31 | 2008-09-15 | $882000 | -$0.14 | ||
| 2008-04-30 | 2008-06-13 | $166000 | -$0.36 | ||
| 2008-01-31 | 2008-03-18 | $52000 | -$0.53 | ||
| 2007-10-31 | 2008-01-15 | $146000 | -$0.29 | ||
| 2007-07-31 | 2007-09-17 | $114000 | -$0.25 | ||
| 2007-04-30 | 2007-04-30 | $96000 | -$0.35 | ||
| 2007-01-31 | 2007-01-31 | $131000 | -$0.44 | ||
| 2006-10-31 | 2006-10-31 | $111000 | -$0.50 | ||
| 2006-07-31 | 2006-07-31 | $131000 | -$0.56 | ||
| 2006-04-30 | 2006-04-30 | $72000 | -$0.64 | ||
| 2006-01-31 | 2006-01-31 | $195000 | -$0.33 | ||
| 2005-10-31 | 2005-10-31 | $49000 | -$0.32 | ||
| 2005-07-31 | 2005-07-31 | $132000 | -$0.31 | ||
| 2005-04-30 | 2005-04-30 | $46000 | -$0.34 | ||
| 2005-01-31 | 2005-01-31 | $213000 | -$0.29 | ||
| 2004-10-31 | 2004-10-31 | $137000 | -$0.25 | ||
| 2004-07-31 | 2004-07-31 | $216000 | -$0.31 | ||
| 2004-04-30 | 2004-04-30 | $102000 | -$0.21 | ||
| 2004-01-31 | 2004-01-31 | $39000 | -$0.25 | ||
| 2003-10-31 | 2003-10-31 | $48000 | -$0.23 | ||
| 2003-07-31 | 2003-07-31 | $83000 | -$0.21 | ||
| 2003-04-30 | 2003-04-30 | $22000 | -$0.33 | ||
| 2003-01-31 | 2003-01-31 | $91000 | -$0.28 | ||
| 2002-07-31 | 2002-07-31 | $1.25 million | -$1.11 | ||
| 2002-04-30 | 2002-04-30 | $2.62 million | $0.33 | ||
| 2002-01-31 | 2002-01-31 | $1.28 million | $0.02 | ||
| 2001-07-31 | 2001-07-31 | $516000 | -$0.36 | ||
| 2001-04-30 | 2001-04-30 | $245000 | -$0.31 | ||
| 2001-01-31 | 2001-01-31 | $178000 | -$0.45 | ||
| 2000-07-31 | 2000-07-31 | $493000 | -$0.39 | ||
| 2000-04-30 | 2000-04-30 | $421000 | -$0.50 | ||
| 2000-01-31 | 2000-01-31 | $277000 | -$0.55 | ||
| 1999-07-31 | 1999-07-31 | -$0.80 | |||
| 1999-04-30 | 1999-04-30 | -$0.68 | |||
| 1999-01-31 | 1999-01-31 | -$0.62 | |||
| 1998-07-31 | 1998-07-31 | -$0.73 | |||
| 1998-04-30 | 1998-04-30 | -$0.78 | |||
| 1998-01-31 | 1998-01-31 | -$0.84 |
Anixa Biosciences, Inc (ANIX) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Jan 31 2021 | Oct 31 2020 | Jul 31 2020 | Apr 30 2020 | Jan 31 2020 |
|---|---|---|---|---|---|
| Research Development | 827651 | 1.66 million | 1.25 million | 1.23 million | 1.49 million |
| Income Before Tax | -2.23 million | -2.24 million | -2.58 million | -2.66 million | -2.62 million |
| Selling General Administrative | 1.53 million | 584034 | 1.18 million | 1.44 million | 1.14 million |
| Gross Profit | 512500 | N/A | N/A | N/A | N/A |
| Ebit | -2.23 million | -2.23 million | -2.39 million | -2.66 million | -2.63 million |
| Operating Income | -2.23 million | -2.24 million | -2.44 million | -2.67 million | -2.63 million |
| Income Tax Expense | N/A | N/A | N/A | N/A | N/A |
| Total Revenue | 512500 | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A |
| Total Other Income Expense Net | N/A | N/A | -148084 | N/A | 13294 |
| Net Income From Continuing Operations | -2.23 million | -2.24 million | -2.58 million | -2.66 million | -2.62 million |
| Net Income Applicable to Common Shares | -2.21 million | -2.22 million | N/A | N/A | -2.59 million |
Cash Flow:
| Date | Jul 31 2020 | Apr 30 2020 | Jan 31 2020 | Oct 31 2019 | Jul 31 2019 |
|---|---|---|---|---|---|
| Investments | -520000 | 249999 | -520000 | -250000 | 650000 |
| Change to Liabilities | 168517 | N/A | -218719 | 18039 | -150142 |
| Total Cash Flow from Investing Activities | -520000 | N/A | -535790 | -250000 | 650000 |
| Net Borrowings | N/A | N/A | N/A | N/A | N/A |
| Total Cash Flow from Financial Activities | 4.85 million | 1.37 million | 1.78 million | 681813 | 564642 |
| Change to Operating Activities | -145565 | N/A | -159982 | -35601 | -7442 |
| Change in Cash | 3.04 million | 66315 | -669743 | -905228 | 574547 |
| Total Cash from Operating Activities | -1.29 million | -1.56 million | -1.91 million | -1.34 million | -640095 |
| Depreciation | 46629 | 14654 | 15310 | 14568 | 56757 |
| Other Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Inventory | N/A | N/A | N/A | N/A | N/A |
| Change to Account Receivables | N/A | N/A | 44216 | -34219 | 795882 |
| Other Cash Flow from Financing Activities | N/A | N/A | N/A | 14034 | N/A |
| Change to Net Income | 1.17 million | N/A | 997302 | 959263 | 804878 |
| Capital Expenditures | N/A | 1 | 15790 | N/A | N/A |
Balance Sheet:
| Date | Jan 31 2021 | Oct 31 2020 | Jul 31 2020 | Apr 30 2020 | Jan 31 2020 |
|---|---|---|---|---|---|
| Total Liabailities | 1.53 million | 1.19 million | 1.22 million | 1.1 million | 1.17 million |
| Total Stockholder Equity | 13.6 million | 8.76 million | 8.62 million | 5.29 million | 5.44 million |
| Other Current Liabilities | 40836 | N/A | N/A | N/A | N/A |
| Total Assets | 14.6 million | 9.45 million | 9.36 million | 5.92 million | 6.16 million |
| Common Stock | 261791 | 242486 | N/A | N/A | 208413 |
| Other Current Assets | 581320 | N/A | N/A | N/A | N/A |
| Retained Earnings | -194.04 million | -191.84 million | -189.61 million | -187.05 million | -184.41 million |
| Other Liabilities | N/A | N/A | N/A | N/A | N/A |
| Other Assets | N/A | 30000 | N/A | N/A | N/A |
| Cash | 11.98 million | 6.42 million | 5.93 million | 2.89 million | 2.82 million |
| Total Current Liabilities | 1.53 million | 1.19 million | 1.21 million | 1.08 million | 1.13 million |
| Other Stockholder Equity | N/A | N/A | N/A | N/A | N/A |
| Property, Plant & Equipment | N/A | 54340 | N/A | N/A | 295268 |
| Total Current Assets | 14.56 million | 9.37 million | 9.26 million | 5.66 million | 5.87 million |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | 13.6 million | 8.76 million | N/A | N/A | 5.44 million |
| Short Term Investments | 2 million | 2.64 million | 3.14 million | 2.62 million | 2.87 million |
| Long Term Debt | N/A | N/A | N/A | N/A | N/A |
| Inventory | N/A | N/A | N/A | N/A | N/A |
| Accounts Payable | 1.48 million | 232368 | 339295 | 170778 | 367098 |
Anixa Biosciences, Inc (ANIX) Chart:
Anixa Biosciences, Inc (ANIX) News:
Below you will find a list of latest news for Anixa Biosciences, Inc (ANIX) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Anixa Biosciences, Inc (ANIX) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|---|---|---|---|---|---|---|---|---|
| 2025-01-17 | 2.5 | 1.1 | CALL | 0 | 560 | 108.49 | TRUE | 0 | 0 |
| 2025-01-17 | 5 | 0.1 | CALL | 0 | 912 | 72.62 | FALSE | 0 | 0 |
| 2025-01-17 | 7.5 | 0.1 | CALL | 0 | 15 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 2.5 | 0.35 | PUT | 0 | 6 | 0 | FALSE | 0 | 0 |
| 2025-01-17 | 5 | 2.7 | PUT | 0 | 8 | 77.16 | TRUE | 0 | 0 |
| 2025-01-17 | 7.5 | 0 | PUT | 0 | 0 | 188.47 | TRUE | 0 | 0 |
| 2025-04-17 | 2.5 | 1.5 | CALL | 0 | 235 | 0 | TRUE | 0 | 0 |
| 2025-04-17 | 5 | 0.55 | CALL | 0 | 443 | 91.53 | FALSE | 0 | 0 |
| 2025-04-17 | 7.5 | 0.3 | CALL | 0 | 33 | 0 | FALSE | 0 | 0 |
| 2025-04-17 | 2.5 | 0.2 | PUT | 0 | 108 | 0 | FALSE | 0 | 0 |
| 2025-04-17 | 5 | 0 | PUT | 0 | 0 | 128.99 | TRUE | 0 | 0 |
| 2025-04-17 | 7.5 | 0 | PUT | 0 | 0 | 106.11 | TRUE | 0 | 0 |
Latest ANIX Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 3:05 PM EST | 100 | $3.32 |
| Jun 13, 2022 1:36 PM EST | 100 | $3.45 |
| Jun 13, 2022 7:46 PM EST | 100 | $3.18 |
Anixa Biosciences, Inc (ANIX) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-07-02 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/715446/000151316220000137/0001513162-20-000137-index.htm |
| 2019-06-18 | UPLOAD | SEC-generated letter | https://www.sec.gov/Archives/edgar/data/715446/000000000019009951/0000000000-19-009951-index.htm |
| 2018-01-30 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/715446/000114420418004436/0001144204-18-004436-index.htm |
| 2018-01-30 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/715446/000114420418004468/0001144204-18-004468-index.htm |
| 2020-09-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/715446/000149315220017421/0001493152-20-017421-index.htm |
| 2020-09-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000149315220017605/0001493152-20-017605-index.htm |
| 2020-09-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000149315220017705/0001493152-20-017705-index.htm |
| 2020-09-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/715446/000149315220017875/0001493152-20-017875-index.htm |
| 2020-11-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000149315220020408/0001493152-20-020408-index.htm |
| 2017-11-22 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/715446/000151316217000313/0001513162-17-000313-index.htm |
| 2017-12-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/715446/000151316217000322/0001513162-17-000322-index.htm |
| 2018-01-09 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/715446/000151316218000006/0001513162-18-000006-index.htm |
| 2018-01-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/715446/000151316218000022/0001513162-18-000022-index.htm |
| 2018-01-26 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/715446/000151316218000036/0001513162-18-000036-index.htm |
| 2018-02-12 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/715446/000151316218000040/0001513162-18-000040-index.htm |
| 2018-02-14 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/715446/000151316218000045/0001513162-18-000045-index.htm |
| 2018-02-15 | SC 13D | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/715446/000151316218000050/0001513162-18-000050-index.htm |
| 2018-03-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/715446/000151316218000056/0001513162-18-000056-index.htm |
| 2018-03-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/715446/000151316218000062/0001513162-18-000062-index.htm |
| 2018-03-27 | 424B5 | Prospectus [Rule 424(b)(5)] | https://www.sec.gov/Archives/edgar/data/715446/000151316218000074/0001513162-18-000074-index.htm |
| 2018-03-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/715446/000151316218000075/0001513162-18-000075-index.htm |
| 2018-04-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/715446/000151316218000088/0001513162-18-000088-index.htm |
| 2018-04-11 | 144 | Report of proposed sale of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316218000094/0001513162-18-000094-index.htm |
| 2018-04-11 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316218000095/0001513162-18-000095-index.htm |
| 2018-04-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316218000096/0001513162-18-000096-index.htm |
| 2018-05-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/715446/000151316218000121/0001513162-18-000121-index.htm |
| 2018-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316218000124/0001513162-18-000124-index.htm |
| 2018-05-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316218000125/0001513162-18-000125-index.htm |
| 2018-06-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/715446/000151316218000161/0001513162-18-000161-index.htm |
| 2018-07-27 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316218000171/0001513162-18-000171-index.htm |
| 2018-07-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/715446/000151316218000172/0001513162-18-000172-index.htm |
| 2018-08-17 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/715446/000151316218000211/0001513162-18-000211-index.htm |
| 2018-09-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/715446/000151316218000230/0001513162-18-000230-index.htm |
| 2018-09-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316218000231/0001513162-18-000231-index.htm |
| 2018-09-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316218000232/0001513162-18-000232-index.htm |
| 2018-09-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316218000233/0001513162-18-000233-index.htm |
| 2018-09-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316218000234/0001513162-18-000234-index.htm |
| 2018-09-18 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316218000235/0001513162-18-000235-index.htm |
| 2018-09-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316218000238/0001513162-18-000238-index.htm |
| 2018-09-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/715446/000151316218000240/0001513162-18-000240-index.htm |
| 2018-10-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/715446/000151316218000247/0001513162-18-000247-index.htm |
| 2018-10-01 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/715446/000151316218000248/0001513162-18-000248-index.htm |
| 2018-10-01 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316218000249/0001513162-18-000249-index.htm |
| 2018-10-01 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316218000250/0001513162-18-000250-index.htm |
| 2018-10-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316218000253/0001513162-18-000253-index.htm |
| 2018-10-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316218000254/0001513162-18-000254-index.htm |
| 2018-10-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316218000255/0001513162-18-000255-index.htm |
| 2018-10-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316218000267/0001513162-18-000267-index.htm |
| 2018-10-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316218000269/0001513162-18-000269-index.htm |
| 2019-01-10 | SC 13D/A | General statement of acquisition of beneficial ownership | https://www.sec.gov/Archives/edgar/data/715446/000151316219000013/0001513162-19-000013-index.htm |
| 2019-01-11 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/715446/000151316219000016/0001513162-19-000016-index.htm |
| 2019-01-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/715446/000151316219000029/0001513162-19-000029-index.htm |
| 2019-03-13 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/715446/000151316219000075/0001513162-19-000075-index.htm |
| 2019-04-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316219000110/0001513162-19-000110-index.htm |
| 2019-04-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316219000111/0001513162-19-000111-index.htm |
| 2019-04-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316219000113/0001513162-19-000113-index.htm |
| 2019-04-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316219000114/0001513162-19-000114-index.htm |
| 2019-04-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316219000115/0001513162-19-000115-index.htm |
| 2019-04-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316219000116/0001513162-19-000116-index.htm |
| 2019-05-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316219000117/0001513162-19-000117-index.htm |
| 2019-05-23 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/715446/000151316219000133/0001513162-19-000133-index.htm |
| 2019-06-11 | S-3 | Registration statement under Securities Act of 1933 | https://www.sec.gov/Archives/edgar/data/715446/000151316219000150/0001513162-19-000150-index.htm |
| 2019-06-12 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/715446/000151316219000156/0001513162-19-000156-index.htm |
| 2019-06-19 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/715446/000151316219000158/0001513162-19-000158-index.htm |
| 2019-07-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/715446/000151316219000164/0001513162-19-000164-index.htm |
| 2019-08-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/715446/000151316219000185/0001513162-19-000185-index.htm |
| 2019-08-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/715446/000151316219000191/0001513162-19-000191-index.htm |
| 2019-09-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/715446/000151316219000202/0001513162-19-000202-index.htm |
| 2019-09-12 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/715446/000151316219000205/0001513162-19-000205-index.htm |
| 2019-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316219000206/0001513162-19-000206-index.htm |
| 2019-09-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316219000207/0001513162-19-000207-index.htm |
| 2019-09-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316219000209/0001513162-19-000209-index.htm |
| 2019-09-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316219000210/0001513162-19-000210-index.htm |
| 2019-09-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316219000212/0001513162-19-000212-index.htm |
| 2019-09-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316219000213/0001513162-19-000213-index.htm |
| 2019-09-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316219000214/0001513162-19-000214-index.htm |
| 2019-10-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/715446/000151316219000221/0001513162-19-000221-index.htm |
| 2019-10-24 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316219000222/0001513162-19-000222-index.htm |
| 2019-10-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316219000223/0001513162-19-000223-index.htm |
| 2019-10-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316219000224/0001513162-19-000224-index.htm |
| 2019-10-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316219000225/0001513162-19-000225-index.htm |
| 2019-10-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316219000226/0001513162-19-000226-index.htm |
| 2019-10-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316219000227/0001513162-19-000227-index.htm |
| 2019-11-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316219000230/0001513162-19-000230-index.htm |
| 2019-12-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316219000249/0001513162-19-000249-index.htm |
| 2019-12-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316219000250/0001513162-19-000250-index.htm |
| 2020-01-09 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/715446/000151316220000009/0001513162-20-000009-index.htm |
| 2020-01-09 | 424B3 | Prospectus [Rule 424(b)(3)] | https://www.sec.gov/Archives/edgar/data/715446/000151316220000010/0001513162-20-000010-index.htm |
| 2020-01-10 | 10-K/A | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/715446/000151316220000012/0001513162-20-000012-index.htm |
| 2020-01-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316220000015/0001513162-20-000015-index.htm |
| 2020-01-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316220000018/0001513162-20-000018-index.htm |
| 2020-01-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316220000019/0001513162-20-000019-index.htm |
| 2020-01-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316220000022/0001513162-20-000022-index.htm |
| 2020-03-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/715446/000151316220000040/0001513162-20-000040-index.htm |
| 2020-03-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316220000042/0001513162-20-000042-index.htm |
| 2020-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316220000047/0001513162-20-000047-index.htm |
| 2020-03-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316220000048/0001513162-20-000048-index.htm |
| 2020-03-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316220000054/0001513162-20-000054-index.htm |
| 2020-04-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/715446/000151316220000088/0001513162-20-000088-index.htm |
| 2020-05-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316220000092/0001513162-20-000092-index.htm |
| 2020-06-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/715446/000151316220000122/0001513162-20-000122-index.htm |
| 2020-06-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316220000123/0001513162-20-000123-index.htm |
| 2020-06-16 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316220000124/0001513162-20-000124-index.htm |
| 2020-06-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316220000127/0001513162-20-000127-index.htm |
| 2020-06-22 | PRE 14A | Other preliminary proxy statements | https://www.sec.gov/Archives/edgar/data/715446/000151316220000129/0001513162-20-000129-index.htm |
| 2020-07-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/715446/000151316220000136/0001513162-20-000136-index.htm |
| 2020-07-02 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/715446/000151316220000137/0001513162-20-000137-index.htm |
| 2020-07-20 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/715446/000151316220000141/0001513162-20-000141-index.htm |
| 2020-08-17 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/715446/000151316220000167/0001513162-20-000167-index.htm |
| 2020-08-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316220000170/0001513162-20-000170-index.htm |
| 2020-08-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316220000171/0001513162-20-000171-index.htm |
| 2020-08-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316220000172/0001513162-20-000172-index.htm |
| 2020-08-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316220000174/0001513162-20-000174-index.htm |
| 2020-08-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/715446/000151316220000175/0001513162-20-000175-index.htm |
| 2019-06-21 | EFFECT | Notice of Effectiveness | https://www.sec.gov/Archives/edgar/data/715446/999999999519001410/9999999995-19-001410-index.htm |
| 2018-02-15 | CT ORDER | Confidential treatment order | https://www.sec.gov/Archives/edgar/data/715446/999999999718000840/9999999997-18-000840-index.htm |
Anixa Biosciences, Inc (ANIX) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Anixa Biosciences, Inc (ANIX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 596%Institutional Ownership: 772%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-09-11 | Lewis H jr Titterton | Director | Buy | 40,000.00 | 2.08 | 83,200.00 | 1,020,326.00 | https://www.sec.gov/Archives/edgar/data/715446/000149315220017705/0001493152-20-017705-index.htm |
| 2019-04-26 | Arnold M Baskies | Director | Buy | 10,000.00 | 4.28 | 42,800.00 | 11,000.00 | https://www.sec.gov/Archives/edgar/data/715446/000151316219000113/0001513162-19-000113-index.htm |
| 2018-09-12 | AMIT KUMAR | Chief Executive Officer | Buy | 4,480.00 | 3.99 | 17,875.20 | 128,888.00 | https://www.sec.gov/Archives/edgar/data/715446/000151316218000231/0001513162-18-000231-index.htm |
| 2018-09-13 | AMIT KUMAR | Chief Executive Officer | Buy | 4,112.00 | 3.96 | 16,283.52 | 133,000.00 | https://www.sec.gov/Archives/edgar/data/715446/000151316218000232/0001513162-18-000232-index.htm |
| 2018-09-13 | AMIT KUMAR | Chief Executive Officer | Buy | 3,000.00 | 3.84 | 11,520.00 | 136,000.00 | https://www.sec.gov/Archives/edgar/data/715446/000151316218000233/0001513162-18-000233-index.htm |
| 2018-09-14 | AMIT KUMAR | Chief Executive Officer | Buy | 3,000.00 | 4.08 | 12,240.00 | 139,000.00 | https://www.sec.gov/Archives/edgar/data/715446/000151316218000235/0001513162-18-000235-index.htm |
| 2018-10-25 | AMIT KUMAR | Chief Executive Officer | Buy | 11,000.00 | 3.90 | 42,900.00 | 150,000.00 | https://www.sec.gov/Archives/edgar/data/715446/000151316218000267/0001513162-18-000267-index.htm |
| 2019-04-24 | AMIT KUMAR | Chief Executive Officer | Buy | 10,000.00 | 4.27 | 42,700.00 | 160,000.00 | https://www.sec.gov/Archives/edgar/data/715446/000151316219000111/0001513162-19-000111-index.htm |
| 2019-04-26 | AMIT KUMAR | Chief Executive Officer | Buy | 4,000.00 | 4.21 | 16,840.00 | 164,000.00 | https://www.sec.gov/Archives/edgar/data/715446/000151316219000114/0001513162-19-000114-index.htm |
| 2019-09-13 | AMIT KUMAR | Chief Executive Officer | Buy | 10,000.00 | 4.12 | 41,200.00 | 174,000.00 | https://www.sec.gov/Archives/edgar/data/715446/000151316219000206/0001513162-19-000206-index.htm |
| 2020-01-14 | AMIT KUMAR | Chief Executive Officer | Buy | 20,000.00 | 2.99 | 59,800.00 | 194,000.00 | https://www.sec.gov/Archives/edgar/data/715446/000151316220000015/0001513162-20-000015-index.htm |
| 2019-04-29 | David Cavalier | Director | Buy | 2,000.00 | 4.21 | 8,420.00 | 2,000.00 | https://www.sec.gov/Archives/edgar/data/715446/000151316219000115/0001513162-19-000115-index.htm |
| 2020-01-17 | Arnold M Baskies | Director | Buy | 10,000.00 | 3.53 | 35,300.00 | 21,000.00 | https://www.sec.gov/Archives/edgar/data/715446/000151316220000022/0001513162-20-000022-index.htm |
| 2020-03-12 | AMIT KUMAR | Chief Executive Officer | Buy | 20,000.00 | 1.82 | 36,400.00 | 214,000.00 | https://www.sec.gov/Archives/edgar/data/715446/000151316220000047/0001513162-20-000047-index.htm |
| 2018-09-18 | Michael Catelani | COO & CFO | Buy | 2,250.00 | 4.45 | 10,012.50 | 2,250.00 | https://www.sec.gov/Archives/edgar/data/715446/000151316218000238/0001513162-18-000238-index.htm |
| 2020-06-12 | AMIT KUMAR | Chief Executive Officer | Buy | 20,000.00 | 2.03 | 40,600.00 | 234,000.00 | https://www.sec.gov/Archives/edgar/data/715446/000151316220000123/0001513162-20-000123-index.htm |
| 2018-04-09 | RICHARD H WILLIAMS | Director | Sell | 25,000.00 | 4.64 | 116,000.00 | 25,000.00 | https://www.sec.gov/Archives/edgar/data/715446/000151316218000096/0001513162-18-000096-index.htm |
| 2020-09-11 | AMIT KUMAR | Chief Executive Officer | Buy | 28,000.00 | 2.11 | 59,080.00 | 262,000.00 | https://www.sec.gov/Archives/edgar/data/715446/000149315220017605/0001493152-20-017605-index.htm |
| 2020-03-06 | Arnold M Baskies | Director | Buy | 10,000.00 | 2.71 | 27,100.00 | 31,000.00 | https://www.sec.gov/Archives/edgar/data/715446/000151316220000042/0001513162-20-000042-index.htm |
| 2020-03-12 | Arnold M Baskies | Director | Buy | 10,000.00 | 1.84 | 18,400.00 | 41,000.00 | https://www.sec.gov/Archives/edgar/data/715446/000151316220000048/0001513162-20-000048-index.htm |
| 2019-04-29 | JOHN J MONAHAN | Director | Buy | 900.00 | 4.22 | 3,798.00 | 50,900.00 | https://www.sec.gov/Archives/edgar/data/715446/000151316219000116/0001513162-19-000116-index.htm |
| 2018-09-14 | Lewis H jr Titterton | Director | Buy | 5,000.00 | 3.98 | 19,900.00 | 839,544.00 | https://www.sec.gov/Archives/edgar/data/715446/000151316218000234/0001513162-18-000234-index.htm |
| 2018-10-25 | Lewis H jr Titterton | Director | Buy | 2,000.00 | 4.05 | 8,100.00 | 841,544.00 | https://www.sec.gov/Archives/edgar/data/715446/000151316218000269/0001513162-18-000269-index.htm |
| 2019-04-22 | Lewis H jr Titterton | Director | Buy | 50,000.00 | 4.09 | 204,500.00 | 891,544.00 | https://www.sec.gov/Archives/edgar/data/715446/000151316219000110/0001513162-19-000110-index.htm |
| 2019-09-13 | Lewis H jr Titterton | Director | Buy | 15,000.00 | 4.10 | 61,500.00 | 906,544.00 | https://www.sec.gov/Archives/edgar/data/715446/000151316219000207/0001513162-19-000207-index.htm |
| 2020-01-14 | Lewis H jr Titterton | Director | Buy | 7,400.00 | 3.22 | 23,828.00 | 913,944.00 | https://www.sec.gov/Archives/edgar/data/715446/000151316220000018/0001513162-20-000018-index.htm |
| 2020-01-15 | Lewis H jr Titterton | Director | Buy | 5,000.00 | 3.32 | 16,600.00 | 918,944.00 | https://www.sec.gov/Archives/edgar/data/715446/000151316220000019/0001513162-20-000019-index.htm |
| 2020-03-13 | Lewis H jr Titterton | Director | Buy | 5,799.00 | 2.12 | 12,293.88 | 924,743.00 | https://www.sec.gov/Archives/edgar/data/715446/000151316220000054/0001513162-20-000054-index.htm |
| 2020-06-15 | Lewis H jr Titterton | Director | Buy | 31,083.00 | 2.27 | 70,558.41 | 955,826.00 | https://www.sec.gov/Archives/edgar/data/715446/000151316220000124/0001513162-20-000124-index.htm |
| 2020-06-16 | Lewis H jr Titterton | Director | Buy | 24,500.00 | 2.27 | 55,615.00 | 980,326.00 | https://www.sec.gov/Archives/edgar/data/715446/000151316220000127/0001513162-20-000127-index.htm |